The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial

Name: The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial
Published: 2020
License: Public Domain

China Medical University Hospital · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

appetite hepatocellular-carcinoma

hepatocellular carcinoma, multiple protein kinase inhibitor therapy, xiang sha liu jun zi decoction, appetite, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial

Related documents